Ascentage Pharma Group International (HKG:6855)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
45.96
+3.20 (7.48%)
At close: Mar 27, 2026

HKG:6855 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,4701,2611,0941,4921,744
Short-Term Investments
-5.376.5611.914.14
Cash & Short-Term Investments
2,4701,2671,1001,5041,748
Cash Growth
95.02%15.10%-26.84%-13.95%70.13%
Accounts Receivable
252.9483.14145.8954.3653.97
Other Receivables
-15.9317.657.1322.48
Receivables
252.9499.07163.5461.4976.45
Inventory
28.626.616.179.453.93
Other Current Assets
192.53101.9164.0861.4156.93
Total Current Assets
2,9441,4741,3441,6361,885
Property, Plant & Equipment
829.06905.56957.07648.72844.37
Long-Term Investments
37.0333.8618.9518.5327.85
Goodwill
24.6924.6924.6924.6924.69
Other Intangible Assets
65.947685.4584.360.41
Long-Term Deferred Tax Assets
31.9644.2459.8454.2951.65
Long-Term Deferred Charges
-30.53---
Other Long-Term Assets
30.7328.7710.22363.2345.81
Total Assets
3,9642,6182,5002,8302,940
Accounts Payable
106.7491.9772.4595.5670.86
Accrued Expenses
-153.33125.68120.6575.32
Short-Term Debt
1,222290120139.9-
Current Portion of Long-Term Debt
-479.62486.65370.4139.8
Current Portion of Leases
-9.449.768.089.65
Current Unearned Revenue
37.4954.0938.4124.3524.36
Other Current Liabilities
276.6788.1781.24122.21141.12
Total Current Liabilities
1,6431,167934.17881.15361.11
Long-Term Debt
757.24868.641,1661,2651,027
Long-Term Leases
-20.7912.929.148.25
Long-Term Unearned Revenue
216.72275.96287.55218.63243.28
Long-Term Deferred Tax Liabilities
-5.3710.5512.1513.75
Other Long-Term Liabilities
12.036.2718.335.3352.34
Total Liabilities
2,6292,3442,4302,4221,705
Common Stock
0.260.210.20.180.18
Additional Paid-In Capital
-6,5455,9515,3935,342
Retained Earnings
--5,771-5,365-4,439-3,557
Treasury Stock
-2.96-0.01-21.35-26.55-0
Comprehensive Income & Other
1,327-510.59-504.46-518.51-550.95
Total Common Equity
1,324264.1960.42408.661,235
Minority Interest
9.759.9710.22--
Shareholders' Equity
1,334274.1670.63408.661,235
Total Liabilities & Equity
3,9642,6182,5002,8302,940
Total Debt
1,9801,6681,7961,7931,084
Net Cash (Debt)
490.37-401.92-695.21-288.58663.68
Net Cash Growth
----33.34%
Net Cash Per Share
1.38-1.33-2.46-1.092.61
Filing Date Shares Outstanding
370.6312.37290.05259.91257.61
Total Common Shares Outstanding
370.6312.37290.05259.91257.61
Working Capital
1,301307.55410.01755.341,524
Book Value Per Share
3.570.850.211.574.79
Tangible Book Value
1,234163.5-49.72299.661,150
Tangible Book Value Per Share
3.330.52-0.171.154.46
Buildings
-836.02834.91470.22406.95
Machinery
-183.34179.87155.2160.98
Construction In Progress
-7.2912.6539.49362.86
Leasehold Improvements
-44.2429.227.748.14
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.